Metformin has been prescribed for type 2 diabetes for more than sixty years. It lowers hepatic glucose production and improves insulin sensitivity, it is inexpensive, and its safety profile is about as well characterised as a drug's can be. None of that is why it keeps appearing in longevity research.
Where the hypothesis came from
It came from an observation rather than a theory: in several large cohort analyses, diabetic patients taking metformin appeared to have mortality outcomes comparable to, and in some analyses better than, matched non-diabetic controls. That is a striking result, and it prompted the obvious question of whether the drug is doing something beyond glucose control.
The mechanism people point to
Metformin activates AMP-activated protein kinase, or AMPK, the enzyme cells use to sense low energy availability. Activated AMPK shifts a cell toward energy production and away from energy-expensive growth, and it overlaps with the pathways that calorie restriction and exercise act on. Those pathways are, in animal models, reliably associated with extended lifespan.
That overlap is real. What it is not, yet, is proof that taking metformin extends healthy life in humans who do not have diabetes.
What would settle it
The TAME trial, Targeting Aging with Metformin, was designed precisely to test this, using the time to a first major age-related event rather than lifespan as its endpoint. It is the study the field is waiting on, and until it reports, the honest position is that the hypothesis is plausible and unproven.
How we treat it here
Metformin appears in some of our protocols, including the TRIIM-style combinations, where it is prescribed for metabolic reasons that stand on their own: insulin resistance, prediabetes, weight management alongside a GLP-1. Those are indications with evidence behind them.
It is worth knowing that long-term metformin use can lower vitamin B12, which is why B12 is checked on the panels of patients taking it. And if a clinic offers you metformin as an anti-aging prescription without testing your metabolic markers first, what you are being sold is the hypothesis, not the medicine.
